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Abstract: This review discusses the prevalence of metabolic syndrome and cardiovascular 
disease in the South Asian population, evaluates conventional and emerging risk factors, and 
reinforces the need for ethnic-specific redefinition of guidelines used to diagnose metabolic 
syndrome. We reviewed recent and past literature using Ovid Medline and PubMed databases. 
South Asians represent one of the largest and fastest growing ethnic groups in the world. With 
this growth, a dramatic rise in the rates of acute myocardial infarction and diabetes is being seen 
in this population. Potential etiologies for this phenomenon include dietary westernization, poor 
lifestyle measures, adverse body fat patterning, and genetics. While traditional risk factors for 
diabetes and cardiovascular disease should not be overlooked, early metabolic syndrome has now 
been shown in the South Asian pediatric population, suggesting that “metabolic programming” 
and perinatal influences may likely play a substantial role. Health care practitioners must be aware 
that current guidelines used to identify individuals with metabolic syndrome are underestimating 
South Asian individuals at risk. New ethnic-specific guidelines and prevention strategies are 
discussed in this review and should be applied by clinicians to their South Asian patients.
Keywords: metabolic syndrome, cardiovascular disease, CVD, heart disease, South Asians
The prevalence of metabolic syndrome (MetS) and cardiovascular disease (CVD) 
among South Asians is increasing. This trend is not only seen in South Asians 
residing on the Indian subcontinent (eg, India, Pakistan, Bangladesh, Nepal), but 
is also observed in countries with large numbers of South Asian immigrants.1 It is 
estimated that 20%–25% of South Asians have developed MetS and many more may 
be prone to it. Urbanization, economic growth, irregular timing of meals, and dietary 
westernization have been suggested as potential culprits implicated in the development 
of this disorder.2 Few studies, however, have investigated the root metabolic and/or 
genetic factors that may play a significant role in this concerning trend.
There is an exceptional need for health care practitioners to recognize the importance 
of MetS and CVD among the South Asian migrant community, especially given the 
population’s rapid growth. South Asians represent one-fifth of the global population.3 
In the United States (US), 3.6 million, or 1.3% of the population, is made up of South 
Asians.4 In fact, as of 2006, Asians as a whole comprise the third largest minority group 
in the US and have been classified as the fastest-growing minority group after Hispanics.5 
In Canada, one million, or about 3% of the population, is made up of South Asians,6 
and South Asians are the largest growing ethnic community in the United Kingdom 
(UK), comprising greater than 46% of that country’s migrant population.7Vascular Health and Risk Management 2009:5 732
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Current guidelines for the criteria used to define MetS 
(Table 1),8–11 including body mass index (BMI) and waist 
circumference (WC), were predominantly modeled after white 
Caucasians and are likely to underestimate MetS and abdominal 
obesity in South Asians.12 It is well known that anthropometric 
measures of South Asians differ when compared to white 
Caucasians and Blacks. South Asians are smaller in size, have 
excess body fat, increased truncal and abdominal obesity, but 
lower waist circumference and BMI when compared to white 
Caucasians.13 The necessity for lower anthropometric set points 
must be recognized by Health care practitioners to ensure early 
diagnosis of MetS in South Asians.
We reviewed recent and past literature using Ovid 
Medline and PubMed (National Library of Medicine, 
Bethesda, MD, USA) databases. Terms that were used 
included ‘South Asia’, ‘India’, ‘Pakistan’, ‘Nepal’, ‘Sri Lanka’, 
‘Bangladesh’, ‘ethnicity’, ‘cardiovascular disease’, ‘myocardial 
infarction’, ‘diabetes’, ‘metabolic syndrome’, ‘anthropometry’, 
‘dyslipidemia’, and ‘obesity’. Table 2 lists primary works cited 
in this review, divided by topic of focus.
Definition of South Asian
The term “South Asian” refers to the 1.5 billion people 
belonging to the southern region of the Asian continent 
comprised of the sub-Himalayan countries. These countries 
include India, Pakistan, Nepal, Sri Lanka, Bangladesh, 
Bhutan, Maldives, and the British Indian Ocean Territory.14 
Anthropologic and genetic studies have demonstrated that 
South Asians have their shared roots within the Indo-Aryan 
and Dravidian cultures.15 This likely explains the unique dif-
ferences that are present in the cardiovascular risk profile and 
body composition of South Asians.16,17 Because there is little 
agreement regarding whether Afghanistan, Tibet, and Iran 
should be classified as South Asian countries, for purposes 
of this review, they were not included.
Cardiovascular disease  
in South Asians
Though there is some heterogeneity in coronary risk 
factors and disease prevalence within the South Asian 
demographic, in Western societies the CVD rate is higher 
Table 1 Definitions of metabolic syndrome
WHO (1999) NCEP ATP III (2001) IDF (2005) EGIR (1999)
Diabetes mellitus, impaired glucose 
tolerance, impaired fasting glucose, 
or insulin resistance* with two 
or more of the following:
Three or more of the 
following:
Central obesity  
(ethnicity-specific)‡  
and two or more  
of the following:
Nondiabetics with insulin 
resistance§ and two or more 
of the following:
Fasting glucose 110 mg/dL (6.1 mmol/L)† 100 mg/dL (5.6 mmol/L) 
or T2DM diagnosis
110 mg/dL (6.1 mmol/L), 
but nondiabetic
Obesity Central obesity (wHR  0.90 
in males or 0.85 in females) 
and/or BMi  30 kg/m2
waist circumference 
102 cm (40 in) in males 
or 88 cm (35 in) in 
females
waist circumference 
94 cm (37.0 in) in males 
or 80 cm (31.5 in) in 
females
Blood pressure 140/90 mm Hg 130 / 85 mm Hg 130 / 85 mmg 
or treatment
140/90 mm Hg 
or treatment
Triglycerides 150 mg/dL (1.7 mmol/L) 150 mg/dL (1.7 mmol/L) 150 mg/dL (1.7 mmol/L) or 
treatment
178 mg/dL (2.0 mmol/L) 
or treatment
and/or and/or
HDL cholesterol 35 mg/dL (0.9 mmol/L) in males 
or 39 mg/dL (1.0 mmol/L) 
in females
40 mg/dL (1.03 mmol/L) 
in males or 50 mg/dL 
(1.29 mmol/L) in females
40 mg/dL (1.03 mmol/L)  
in males, 50 mg/dL 
(1.29 mmol/L) in females, 
or treatment
39 mg/dL (1.0 mmol/L) 
or treatment
Other Microalbuminuria (urinary albumin 
excretion rate 20 mg/min or 
albumin:creatinine ratio 30 mg/g)
Notes: *Refer to WHO publication for definitions of hyperglycemic states. Insulin resistance defined as glucose uptake below lowest quartile for background population under 
investigation, in hyperinsulinemic, euglycemic conditions. †Revised in 2004 to 100 mg/dL (5.6 mmol/L) to reflect the American Diabetes Association’s updated definition of 
impaired fasting glucose.9,132 ‡Defined as 94 cm (males) or 80 cm (females) in Europids and 90 cm (males) or 80 cm (females) in South Asians, among others. §Defined 
as the 25% of the nondiabetic population with the highest insulin resistance or the highest fasting insulin concentrations.
Abbreviations: BMi, body mass index; EGiR, European Group for the Study of insulin Resistance; HDL, high-density lipoprotein; iDF, international Diabetes Federation; NCEP 
ATP iii, National Cholesterol Education Program Adult Treatment Panel;   T2DM, type 2 diabetes mellitus;   wHO, world Health Organization; wHR, waist-to-hip ratio.Vascular Health and Risk Management 2009:5 733
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among South Asians compared to indigenous Caucasians.16 
Additionally, despite falling CVD-related mortality among 
whites, CVD mortality among South Asians is decreasing at 
a significantly slower pace.1 In an epidemiologic study exam-
ining coronary heart disease (CHD) mortality for six ethnic 
groups in California from 1990–2000, the proportional mor-
tality rates for CHD were the highest for Asian Indian men 
and women. Of note, all six ethnic groups except Asian Indian 
women showed a decline in all-cause and CHD mortality in 
this period as compared to the period between 1985 and 1990. 
Asian Indian women experienced a 16% increase in all-cause 
mortality and a 5% increase in CHD mortality.18 In a similar 
Canadian study looking at various ethnic groups between 
1979 and 1993, South Asians had the highest CHD mortality 
when compared to individuals of Chinese and European 
descent.19 Multiple other studies of the migrant South Asian 
population demonstrate a three- to five-fold increase in the 
risk for myocardial infarction and cardiovascular death when 
compared to other ethnic groups.20–22
In India, CVD was the leading cause of mortality in 2005, 
accounting for 39% of deaths.23 Although urbanization is 
often identified as the culprit, rural Indian populations are 
similarly affected. Epidemiologic data from rural portions 
of South India in 2005 revealed that 32% of all deaths 
were due to CVD, outranking infectious disease, which 
was responsible for 13% of deaths.24 The CREATE study 
prospectively analyzed over 20,000 patients with acute coro-
nary syndrome (ST segment elevation myocardial infarction 
[STEMI], non-ST segment elevation myocardial infarction 
[NSTEMI], or unstable angina [UA]) at over 89 centers 
across India. Mean patient age was 57.5 years, and 60.6% of 
the patients presented with STEMI. A large proportion of the 
patients belonged to lower middle (52.5%) and poor (19.6%) 
socioeconomic classes. Socioeconomic status (SES) was 
shown to be highly related to outcome, with higher 30-day 
mortality rates for those in the poor SES group compared 
to those in the wealthy group (8.2% vs 5.5%; p  0.0001). 
Also, those in the lower socioeconomic strata were less likely 
to receive evidence-based medical treatment.25 Globally, 
mean age of presentation for first acute myocardial infarction 
(AMI) varies between South Asian countries (Table 3).26 
Inhabitants of Bangladesh have the earliest incidence of 
Table 2 Cited primary works relating to metabolic syndrome and cardiovascular disease in South Asians
Topic of focus Studies in native populations Studies in migrant populations
Cardiovascular outcomes 
and epidemiology
Joshi,24 Xavier,25 Joshi,26 Yusuf,48 Deepa111 Palaniappan,18 Sheth,19 Harding,20 Tuomilehto,22 
McKeigue,32 Singh,33 Gupta,34 wilkinson,35 Patel,36 
Miller53,54
Traditional cardiovascular 
risk factors
Joshi,26   Yusuf,48 Hodge,50 Lubree,58 Rastogi61 Bhopal,16,73 Enas,29 Singh,33 Gupta,34 Patel,36 Anand,45 
Miller,54 Tai,55 Bhatnagar,88 Miller,112 Kamath,122 Lear127
Diabetes mellitus Mohan,38 Sayeed,39 Lubree,58 Snehalatha,100 
Jafar126
Tuomilehto,22 Patel,36 Venkataraman,44 Tai,55 McKeigue57
Hypertension Jafar,126 Mohan135 Patel36
Obesity Mohan,38 Sayeed,39 Yajnik,118,142 Jafar,126 Mohan,135 
Bavdekar139
Chandalia,119 Razak124
Lipid disturbances Reddy,60 Gambhir,82 Gupta,83 Misra117 Bhopal,16 Enas,29 Gama,49 Kulkarni,52 Miller,53 Tai,55 
Hoogeveen,89 Kamath,122 Lovegrove,128 Kalhan121*
Emerging cardiovascular risk 
factors
Joshi,26 Yusuf,48 Gambhir,82 Gupta,83 Deepa,97 
Snehalatha,100 Gheye S101
Anand,45,95 Hughes,51 Hoogeveen,89 Chambers,96,102,104 
Raji,99 Chandalia103
Metabolic syndrome Mohan,110 Deepa,111 Vikram144 Hughes51
insulin resistance Hodge,50 Deepa,97 Yajnik,136,142 Bavdekar,139 
Vikram144
Hughes,51 Tai,55 McKeigue,57 Liew,98 Raji,99 Banerji,108 
Sharp,113 Chandalia,119 Chowdhury,120 Forouhi,125 
Lovegrove,128 Kalhan,121* whincup134*
Anthropometry Dudeja,115 Misra,117 Mohan,123 Jafar,126 Misra,131 
Vikram144
Patel,17 Razak,124 Lear,127 whincup133*
Fat patterning Hodge,50 Lubree,58 Dudeja,115 Misra,117 
Yajnik118,136
Hughes,51 McKeigue,57 Banerji,108 Chandalia,119 
Chowdhury,120 Forouhi,125 Lovegrove128
Pediatric and developmental 
considerations
Yajnik,118,136,142 Mohan,135 Bavdekar,139 Vikram144 Kalhan,121* whincup133,134*
Other Mohan110 Dhawan,30 Gupta,31 Abraham,66 Matthews,68 Bhopal73
Note: *Study involves the offspring of migrants.Vascular Health and Risk Management 2009:5 734
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AMI, with a mean age of 51.9 ± 11.0 years, while those 
from Nepal have the latest, with a mean age at first AMI of 
58.9 ± 11.8 years.26 These data suggest that though South 
Asians share many epidemiologic similarities, there remains 
some heterogeneity among South Asian populations and 
CVD burden.
Compared to whites, individuals of South Asian descent 
demonstrate CHD onset at a younger age27,28 and are often 
diagnosed with CHD before the age of 40.26,29 South Asians, 
compared to white Caucasians, are also younger at the time 
of first cardiac catheterization, and they are more likely to 
have significant left main, multivessel, and distal coronary 
artery disease.30–32 South Asians are also diagnosed with con-
gestive heart failure at a younger age.33 A case control study 
performed in Canada between 1994 and 1999 examining 
South Asians set against non-South Asian matched controls 
presenting with AMI demonstrated that South Asians present 
with more anteriorly located infarctions (28.2% vs 21.3%; 
p = 0.007), and there was a trend toward a higher rate of 
coronary artery bypass grafting (4.2% vs 2.2%; p = 0.06). 
Infarct size, rate of thrombolytic therapy, in-hospital proce-
dure rate, length of hospitalization, and in-hospital mortality 
were the same, however. Pre-existing diabetes was much 
more common in the South Asian group than in the control 
group (43.4% vs 28.2%; p  0.001), as was lower BMI (25.7 
vs 28.0; p = 0.05). Simultaneously, South Asians were less 
likely to be former or current cigarette smokers (29.3% vs 
67.8%; p  0.001), and they had a lower rate of peripheral 
vascular disease (7.0% vs 15.6%; p  0.001).34
A British observational study revealed that South 
Asians had a higher six-month mortality rate after hospital 
presentation with AMI when compared to their white 
counterparts, after adjusting for age, sex, previous myocardial 
infarction, and treatment with thrombolysis and/or aspirin 
(hazard ratio [HR], 2.02; 95% confidence interval [95% CI]: 
1.14–3.56; p = 0.018). Again noted was the substantially 
higher proportion of diabetics in the South Asian group (38% 
vs. 11%; p  0.001). Adjustments for diabetes, however, 
mitigated much of the increased risk among South Asians 
(adjusted HR, 1.26; 95% CI: 0.68–2.33; p = 0.47). This 
suggests diabetes may be contributing to South Asians’ 
increased risk of death from CVD.35
Conventional risk factors
Diabetes mellitus, known to be an independent, significant 
risk factor for CVD and a predictor of AMI,36 is also on 
the rise among South Asians. In India, it is estimated that 
32 million people suffer from diabetes, and that number is 
projected to increase to 69.8 million by 2025.37 There does 
appear to be significant difference in diabetes prevalence 
between socioeconomic classes. A national noncommuni-
cable disease risk factor surveillance study conducted in 
India from 2003 to 2005, examining 44,523 individuals, 
showed that the highest prevalence of self-reported physician-
diagnosed diabetes mellitus was seen in urban residents with 
abdominal obesity and sedentary lifestyle (11.3%), followed 
by active urban residents without abdominal obesity (7.3%), 
peri-urban/slum residents (3.2%), and residents of rural areas 
(3.1%). Highly active rural residents without abdominal obe-
sity had the lowest prevalence of diabetes (0.7%).38 Similar 
results were reported in a recent study comparing urban 
dwellers to slum dwellers in Dhaka, Bangladesh, demonstrat-
ing that income, family history, age, sedentary lifestyle, BMI 
and waist-to-hip ratio (WHR) were the strongest predictors 
of developing diabetes in this population.39
The prevalence of diabetes is higher among South Asian 
migrants as compared to those living in urban areas of South 
Asia. In the UK, the prevalence of DM in Pakistanis and 
Bangladeshis has been reported to be between 15%–20%.40 
In a community-based study primarily examining vegetarian 
Indians in the US, the prevalence of DM was 18.3%. These 
figures are considerably higher than the prevalence of DM 
seen in Hispanics, Blacks, and Caucasians in the US, as 
current estimates reveal that 6%–8% of the US population 
suffers from diabetes, with the true prevalence approaching 
10% when undiagnosed diabetes is taken into account.41–44
Along with DM, other traditional risk factors play a 
significant role in the determination of CVD. Despite higher 
rates of CHD-related death and earlier onset of AMI, prior 
Table 3 Distribution of acute myocardial infarction cases in the 
iNTERHEART study
No. of 
cases
Mean age ± SD  
at first AMI, years
% (No.) of cases 
before age 40
worldwide, 
excluding 
South Asia
10728 58.8 ± 12.2 5.6% (599)
South Asian 
countries
1732 53.0 ± 11.4 8.9% (154)
  india 470 53.0 ± 11.4 11.7% (55)
  Pakistan 637 53.3 ± 11.1 8.9% (57)
  Sri Lanka 153 57.7 ± 11.3 5.9% (9)
  Bangladesh 228 51.9 ± 11.0 10.5% (24)
  Nepal 244 58.9 ± 11.8 3.7% (9)
Note: Copyright © 2007, American Medical Association.   Adapted with permission 
from Joshi P, islam S, Pais P, et al. Risk factors for early myocardial infarction in South 
Asians compared with individuals in other countries. JAMA. 2007;297(3):286–94.
Abbreviations: AMi, acute myocardial infarction; SD, standard deviation.Vascular Health and Risk Management 2009:5 735
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studies have depicted an apparent lower prevalence of 
traditional cardiovascular risk factors in South Asians.32,45–47 
This raises the concern that South Asians demonstrate 
a special susceptibility to AMI that is not explained by 
traditional risk factors. The landmark INTERHEART 
case control study, which examined over 15,000 patients 
in 52 countries with first presentation of AMI, did not 
support this hypothesis. The analysis demonstrated that nine 
potentially modifiable cardiovascular risk factors (Table 4)26,48 
contributed similarly to AMI risk among native South Asians 
and individuals from other countries. Combined, these nine 
risk factors accounted for 85.8% (95% CI: 78.0%–93.7%) 
of the population-attributable risk (PAR) for AMI among 
native South Asians and 88.2% (95% CI: 86.3%–89.9%) of 
the PAR among individuals from other parts of the world, 
suggesting that traditional risk factors for CVD should not 
be overlooked in South Asians.26
The INTERHEART study further demonstrated that 
smoking history, hypertension, and adverse psychosocial 
factors (depression and stress at work or home) were also 
strongly associated with increased risk of AMI (p  0.001) 
in native South Asians. Daily intake of fruits and vegetables 
(p  0.001), as well as physical activity (p = 0.03), were 
protective against AMI. Interestingly, although regular 
alcohol consumption ( once per week) was protective in 
other populations studied (odds ratio [OR], 0.79; 95% CI: 
0.74–0.85), it was not protective among native South Asians 
(OR, 1.06; 95% CI: 0.85–1.30; p for interaction = 0.02), and 
it was associated with increased harm in the Indian subgroup 
(OR, 1.64; 95% CI: 1.21–2.27).26 This may be attributable 
to differences in drinking prevalence or patterns of drinking 
in South Asian countries.
Lipid profiles consistent with MetS definitions are 
also being seen in the South Asian demographic. South 
Asians of both sexes have low levels of high-density 
lipoprotein (HDL),49–55 with the lowest levels in native, 
urban dwelling Indians as well as in migrant Indians. Those 
living in rural areas have shown comparatively higher 
levels of HDL. Nevertheless, all segments of the Indian 
demographic have lower HDL levels when compared to 
native Caucasians.56 Similar social strata differences are 
being seen with triglyceride levels. Hypertriglyceridemia is 
more common in migrant Indians50,57 and native Indians of 
higher socioeconomic class58,59 when compared to the rural 
Indian population.56,60 Although low-density lipoprotein 
(LDL) levels in South Asians are comparable to levels seen 
in whites, South Asians are demonstrating higher levels of 
the more atherogenic small-dense LDL.52
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Considering protective factors, physical activity was 
among the lowest for South Asians when compared to other 
groups studied in INTERHEART (6.1% vs 21.6%).26 A recent 
Indian study demonstrated a 50% reduction in CHD risk 
in participants that engaged in moderate physical activity 
for 30–45 minutes daily.61 Multiple studies have further 
demonstrated the beneficial effects of exercise on general 
anthropometric measures and metabolic parameters such 
as central obesity, LDL, HDL, development of diabetes and 
hypertension.61–65 Given the prevalence of these factors in 
the South Asian population, the importance of engaging in 
daily exercise must be stressed.
In a region where vegetarianism predominates, the intake 
of fruits and vegetables (1 serving/day) in South Asia is 
surprisingly low as seen in INTERHEART (26.5 vs  45.2%).26 
Among those who do regularly eat vegetables, the amount 
of cardiovascular benefit conferred remains questionable. 
Prolonged cooking of vegetables, a practice common in South 
Asian households, may significantly alter the vegetables’ 
nutritional makeup and eliminate up to 90% of the original 
folate content.66–68 Published literature has consistently dem-
onstrated that intake of fresh fruits and green leafy vegetables 
lowers the risk of CHD, with significant direct correlations 
observed between number of servings and cardiovascular 
risk reduction.69–72
Variations in the distribution of CVD and associated risk 
factors have been observed among South Asian countries, 
with Bangladesh faring the worst. It is the country with lowest 
mean age at incidence of AMI, and among INTERHEART 
control subjects, it has the highest prevalence of most risk fac-
tors studied: current and former smoking (59.9%), elevated 
apolipoprotein B100 (ApoB100)/apolipoprotein A-I (ApoA-I) 
ratio (59.7%), abdominal obesity (43.3%), self-reported 
history of hypertension (14.3%), and depression (43.0%). 
Furthermore, amongst the protective factors, Bangladesh 
has the lowest prevalence for regular physical activity 
(1.3%) and daily intake of fruits and vegetables (8.6%).26 
Similar heterogeneity in cardiovascular risk factors has been 
observed among South Asian migrant groups living in the 
UK. Bangladeshi migrants have the highest prevalence of 
coronary risk factors such as smoking and inactivity when 
compared to Indians and Pakistanis, while Indians have the 
lowest prevalence of these risk factors among the group. 
Additionally, the metabolic profiles of Bangladeshi migrants 
demonstrate the highest levels of triglycerides, LDL, and fast-
ing glucose and the lowest levels of HDL when compared to 
Pakistanis, Indians, and Europeans.16 Some UK studies have 
suggested that differences within migrant populations may 
in part be attributed to socioeconomic disparities between 
South Asian groups, with UK Indian migrants appearing to 
be more socioeconomically advantaged than their Pakistani 
and Bangladeshi counterparts.16,73 In general, however, 
socioeconomic data on migrant groups are limited.
Emerging risk factors
Along with traditional risk factors, emerging factors present 
in the South Asian population are allowing for further CHD 
risk stratification. At the forefront is the ApoB100/ApoA-I 
ratio. ApoB100 is the major apolipoprotein found in LDL, 
intermediate-density lipoprotein (IDL), and very low-density 
lipoprotein (VLDL), and it is the primary ligand for the 
LDL receptor. ApoA-I is the major protein constituent of 
HDL. The ApoB100/ApoA-I ratio provides an atherogenic 
to antiatherogenic lipoprotein ratio that has been shown to 
be a better predictor of CVD than LDL level, HDL level or 
LDL/HDL ratio.74–77 Furthermore, the ApoB100/ApoA-I ratio 
can identify individuals with a preponderance of small dense 
LDL particles, but with seemingly normal LDL levels.78 
INTERHEART was among the first studies to demonstrate 
that an elevated ApoB100/ApoA-I ratio was the risk factor 
associated with the highest PAR (46.8%) for AMI in South 
Asians, with WHR (37.7%) and current and former smoking 
(37.5%) following close behind.26
Lipoprotein(a) [Lp(a)], considered an emerging risk 
factor by National Cholesterol Education Program Adult 
Treatment Panel III (NCEP ATP III), has been implicated 
in the development of the premature atherosclerotic disease 
seen in South Asians.79–83 It represents a class of LDL 
particles that contains the plasminogen-like apolipoprotein(a) 
moiety attached to an ApoB100 protein moiety. Unlike other 
lipids that are influenced by diet, age, gender and other 
environmental factors, Lp(a) levels have been shown to be 
primarily driven by genetics and ethnicity.84–87 A recent UK 
study demonstrated that Lp(a) concentrations were similar 
in migrant Indians living in the UK when compared to their 
matched siblings living in India. This is in spite of the fact 
that the matched siblings living in India had significantly 
lower BMI, lower total cholesterol, higher HDL, lower apoB 
concentrations, lower systolic and diastolic blood pressures, 
and lower fasting blood glucose. This study found that Lp(a) 
levels were higher in migrant and native Indians when 
compared to matched European controls.88
In the general Caucasian population, Lp(a) concentration 
greater than 30 mg/dL is considered to be a risk factor for 
premature CHD. In South Asians, however, levels less than 
20 mg/dl are considered optimal.83,89 Lp(a) levels between Vascular Health and Risk Management 2009:5 737
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20 and 30 mg/dl are associated with a two- to three-fold 
increased risk of AMI and restenosis following coronary 
angioplasty or coronary artery bypass grafting.90–92 When 
combined with other lipid abnormalities, the risk of AMI is 
further increased. AMI risk increases 10-fold when Lp(a) 
levels are greater than 50 mg/dl in conjunction with increased 
total cholesterol levels. When levels are greater than 55 mg/dl 
and combined with low HDL and high total cholesterol 
(TC)/HDL ratio, AMI risk increases 100-fold.81,93,94
Other emerging risk factors that may contribute to the 
pathogenesis of premature CHD in South Asians include 
inflammatory biomarkers such as C-reactive protein 
(CRP),95,96 interleukin 6 (IL-6),97 and other adipokines98–100 
and thrombotic risk factors such as fibrinogen101 and plas-
minogen activator inhibitor-1 (PAI-1).45,89 Elevated levels of 
CRP, a marker of inflammation, are an independent risk fac-
tor for CHD. A cross-sectional analysis of 1,025 healthy male 
subjects in the UK described higher concentrations of CRP 
in Indians compared to white Caucasians. CRP levels were 
strongly associated with traditional CHD risk factors in both 
groups.96 Abnormalities in markers of endothelial dysfunc-
tion, such as vascular cell adhesion molecule 1 (VCAM-1),97 
elevated homocysteine levels,102,103 and impaired endothelium 
dependent dilatation104 have also been described in South 
Asian populations. A recent study demonstrated that fasting 
plasma homocysteine concentration was associated with 
CHD independent of conventional cardiovascular risk factors 
in Europeans and Indians in the UK Among 1,025 healthy 
male controls, fasting homocysteine concentrations were 
6% higher in Indians compared to Europeans.102 A US study 
similarly depicted higher levels of homocysteine in Indians 
than in white Caucasians.103 Further study will delineate the 
magnitude of cardiovascular risk that these and other novel 
markers may confer on South Asians.
Metabolic syndrome  
and anthropometric measures
Metabolic syndrome represents a clustering of CVD-related 
risk factors of which there are a variety of definitions 
(Table 1). United among these definitions is the occurrence 
of abdominal adiposity, hyperinsulinemia, hypertension, 
and elevated triglyceride/HDL ratio. Individuals who meet 
these criteria are at increased risk for development of CHD 
and diabetes mellitus105 and have a two-fold increased risk 
of all-cause mortality and a two- to three-fold increased 
risk of cardiovascular death.106 For this reason, health care 
providers should aggressively target these patients for 
lifestyle modification counseling, specific pharmacologic 
interventions, and additional risk factor assessment before 
the onset of cardiovascular illness.
Fundamental to MetS is the phenomenon of insulin 
resistance, which is the state in which insulin produces a 
subphysiologic effect on glucose metabolism. Invariably, 
this condition is accompanied by progressive compensatory 
hyperinsulinemia.107 Insulin resistance is especially preva-
lent in South Asians, who have consistently been shown to 
have impaired markers of insulin sensitivity, such as higher 
fasting and post-glucose serum concentrations of insulin, 
when compared to whites and other ethnic groups.13,57,98,99,108 
The disproportionately high prevalence of insulin resis-
tance, in addition to central obesity, in these populations 
may explain the higher prevalence of diabetes and CVD in 
South Asians.13,57 Additionally, insulin resistance has been 
implicated in the development of nonalcoholic fatty liver 
disease (NAFLD), a common cause of chronic liver disease 
in the West and independent risk factor for cardiovascular 
events in diabetics.109 Though NAFLD appears to be common 
in Indian populations and increases in prevalence with wors-
ening glucose intolerance,110 more investigation is required 
to determine the exact nature and pathologic significance of 
NAFLD in South Asians.
The NCEP ATP III definition of MetS, which is commonly 
used in the US and Europe, significantly underestimates MetS 
in the South Asian population. In a recent South Indian 
study, the prevalence of MetS was estimated to be 25.8%, 
23.2%, and 18.3% according to the International Diabetes 
Federation (IDF), World Health Organization (WHO), and 
NCEP ATP III definitions, respectively.111 Though its rec-
ommendation that special attention be given to detection of 
CHD risk factors and mitigation of MetS in South Asians is 
insightful, the NCEP ATP III criteria for defining MetS are 
not sufficiently sensitive, as they fail to adequately capture 
abdominal obesity in the South Asian population. Adiposity 
has been shown to correlate with increased insulin resistance 
and hyperinsulinemia.112,113 South Asians have a higher 
percentage of body fat at a lower BMI when compared to 
whites and blacks.110,114–118 Adiposity in South Asians thereby 
tends to present as a greater amount of intra-abdominal 
fat,116,117 a thicker truncal skinfold, and a lower amount of 
lean body mass.54,108,112,119–122
An analysis of the Chennai Urban Rural Epidemiology 
Study (CURES) study demonstrated that the optimal BMI 
cutoff point for identifying two cardiometabolic risk factors 
was 23 kg/m2 for Indians of both sexes and a WC of 87 cm 
for men and 82 cm for women.123 A recent 2006 study of 289 
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points of 22.5 kg/m2 for lipid metabolism and 21 kg/m2 for 
glucose metabolism.124 These findings are concordant with 
other studies demonstrating elevated risk of type 2 diabetes, 
hypertension, and dyslipidemia in South Asians with BMI 
under 25.0 kg/m2.125–129 Findings such as these have prompted 
the WHO to release a statement defining overweight in 
Asian-Pacific Islanders as a BMI  23.0 kg/m2 and obesity 
as a BMI  25.0 kg/m2.130
Unlike NCEP ATP III, the IDF definition for MetS 
accounts for the differences that exist between ethnicities. 
It makes abdominal obesity a central requirement for defining 
MetS and provides ethnicity-specific WC cutoffs. For South 
Asian men, the WC cutoff is 90 cm, and for women, it 
is 80 cm (for whites, 94 cm in men and 80 cm in 
women). The use of new ethnicity-specific WC cutoff points 
has been shown to identify South Asians with the high-
est risk of having cardiovascular risk factors.131 The IDF 
definition of MetS also utilizes the lower fasting glucose 
cutoff of 100 mg/dl, a level consistent with the American 
Diabetes Association’s revised 2003 definition of impaired 
fasting glucose.132 In 2004, the NCEP also moved to accept 
this more inclusive cutoff point.
The emerging generation  
of South Asians
Susceptibility to MetS and CVD has now been shown 
in South Asian children. Compared to white Caucasian 
children in the UK, South Asian children demonstrate 
higher mean fasting and post-glucose load insulin con-
centrations, increased mean heart rate, and elevated mean 
serum triglyceride and fibrinogen levels.133 Furthermore, 
despite higher indices of adiposity in South Asian children 
when compared to white UK Caucasian children, increased 
prevalence of insulin resistance persisted after adjusting 
for adiposity and pubertal status.134 Correlating with BMI, 
hypertension is also being seen in South Asian children. 
In urban Indian children, hypertension prevalence is 4.5% 
in those with normal BMI, 15% in overweight children, and 
43% in obese children. Similar estimates of prevalence are 
seen in rural Indian children.135
In Indian neonates, relative weight-adjusted hyperinsu-
linemia and adiposity compared to white neonates has been 
recorded at birth, suggesting that a genetic susceptibility may 
be an important contributing factor in the development of 
MetS.136 It has been well established that large-for-gestational 
age infants born to diabetic or obese mothers are at increased 
risk for the development of MetS in childhood.137 Current 
evidence demonstrates that low birth weight babies are less 
insulin sensitive than those in a normal weight group.138 
At eight years of age, Asian Indian babies born small for 
gestational age have higher total and LDL-C concentrations, 
higher systolic blood pressure, and increased adiposity.139 
These findings support the model suggesting in utero 
development of MetS.140–142 Further research is needed to 
establish the impact of perinatal and genetic influences in 
the development of MetS.
Aside from native and migrant South Asians, research 
has shown that children of South Asians born and raised 
in Western Societies also have altered metabolic profiles 
when compared to their white Caucasian counterparts. 
A study performed in 2000 at Case Western Reserve 
University (Cleveland, OH, USA) compared metabolic 
and anthropometric measures of young adults of South 
Asian descent, born and raised in the US (n = 32; mean 
age = 24; BMI = 22.1), to their white Caucasian counter-
parts (n = 29; mean age = 24; BMI = 23.7). By examin-
ing a group of first-generation South Asian Americans, 
the study sought to control for environmental variables 
inherent to immigrant populations. South Asian males in 
the study had significantly higher TC, LDL, TC:HDL ratio, 
triglycerides, and fasting insulin levels and lower HDL than 
their white counterparts. South Asian females demonstrated 
higher plasma insulin levels than white Caucasian females. 
The entire South Asian group had higher truncal skinfold 
thickness and lower insulin-like growth factor-binding 
protein-1 (IGFBP-1) levels. Plasma leptin levels were also 
significantly higher in South Asian subjects, while no dif-
ferences were observed in lean body mass, homocysteine, 
or serum Lp(a). These findings point to an altered metabolic 
profile in young South Asian Americans that supports a 
genetic predisposition to altered body fat patterning and the 
MetS. Further prospective studies are needed to determine 
if these differences place this population at increased risk 
of cardiovascular morbidity.121
Defining MetS in South Asian children and adolescents 
poses a diagnostic challenge, as an ethnicity-specific MetS 
definition for the pediatric population does not exist. Further-
more, estimates of the prevalence of MetS in other ethnicities 
vary widely based on the definition applied.143 A recent Indian 
study of adolescents demonstrated a 0.8% prevalence of MetS 
using the NCEP ATP III criteria with appropriate percentile 
cutoffs. The prevalence increased to 4.2% with inclusion 
of fasting hyperinsulinemia as an additional criterion and 
to 10.2% when BMI and WC were included.144 Given the 
increasing prevalence of diabetes mellitus and obesity in 
childhood and adolescence, ethnic-specific criteria for MetS Vascular Health and Risk Management 2009:5 739
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are needed in the pediatric population for early recognition 
and implementation of therapeutic strategies.
Clinician’s take home points
1.  Health care professionals and South Asian patients must 
be educated on the predilection toward MetS, diabetes 
mellitus, and premature CVD in the South Asian 
demographic.
2.  CVD risk in South Asians increases as the number 
of traditional risk factors increase (eg, smoking, lack 
of exercise, and decreased intake of fresh fruits and 
vegetables). The landmark INTERHEART study 
demonstrated that the PAR for AMI based on the 
combined presence of nine potentially modifiable risk 
factors in native South Asians equaled 85.8% (95% CI: 
78.0%–93.7%), suggesting that traditional risk factors 
for CVD should not be overlooked in South Asians. 
An elevated ApoB100/ApoA-I ratio was the risk factor 
associated with the highest PAR (46.8%) for AMI in 
South Asians, with WHR (37.7%) and current and former 
smoking (37.5%) following close behind. Furthermore, 
INTERHEART demonstrated that alcohol consumption 
(1 drink per week) has no beneficial effect in the South 
Asian population and may actually have a harmful effect 
in Asian Indians.
3.  Assessment of emerging risk factors (eg, CRP, 
homocysteine, Lp(a), adipokines) may be undertaken to 
further quantify CVD risk.
4.  South Asians comprise a heterogeneous population at 
increased risk for CVD. Among native and migrant 
South Asians, Bangladeshis fare the worst. They have 
the youngest mean age at incidence of AMI and the high-
est prevalence of cardiac risk factors. Early therapeutic 
strategies and counseling on lifestyle modification must 
be especially targeted to this demographic.
5.  The International Diabetes Federation (IDF) definition 
for MetS, which is ethnicity-specific, represents the 
best diagnostic tool in capturing MetS in the South 
Asian population. WC cut-points should be maintained 
at 90 cm for men and 80 cm for women. Studies have 
shown that the optimal BMI for South Asians should be 
maintained between 18.5 and 23 kg/m2.
6.  MetS has now been shown to be present in the South 
Asian pediatric population. This is likely a result of 
genetic predisposition, perinatal factors, and the influence 
of South Asian culture and dietary habits from an early 
age. Currently, there are no ethnic-specific criteria for 
identifying MetS in young South Asians.
7.  Prevention strategies must be discussed with all South 
Asian patients. Emphasis should be placed on identifying 
and reducing cardiovascular risk factors, encouraging 
proper nutrition and exercise, and initiating appropriate 
pharmacologic interventions when indicated.
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